Short-acting insulin market set for growth, finds industry analyst

The short-acting insulin market is poised for significant growth, driven by a rising prevalence of diabetes, technological advancements, and evolving healthcare policies.

According to DelveInsight's latest report, North America is expected to dominate the global short-acting insulin market throughout the forecast period, supported by an aging population, increasing obesity rates, and more sedentary lifestyles.

The region's focus on diabetes awareness and educational programs further bolsters demand for short-acting insulin, which is essential for managing blood glucose levels in diabetic patients.